AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26892001 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) coupled with Virtual Reality Exposure Therapy (VRET)
Number of subjects: 120
Study 26892001 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy (CBT) alone
Number of subjects: 120
Study 25315148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal questionnaires assessing physical activity (Godin score)
Number of subjects: 903
Study 25315148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal questionnaires assessing diet (DINE Fibre score)
Number of subjects: 903
Study 25315148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal questionnaires assessing diet (DINE Total Fat score)
Number of subjects: 903
Study 22395336 — intervention group
Group type: EXPERIMENTAL
Intervention: WATCHMAN Left Atrial Appendage Closure Device
Number of subjects: 6000000
Study 22395336 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 6000000
Study 22395336 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 6000000
Study 22395336 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran (150 mg twice a day)
Number of subjects: 6000000
Study 22395336 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban
Number of subjects: 6000000
Study 20665351 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg chest optimization (TCO)
Number of subjects: 12
Study 20665351 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT following TCO
Number of subjects: 12
Study 17386112 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest transthoracic echocardiography (TTE) and Dobutamine stress echocardiography (DSE)
Number of subjects: 20
Study 17386112 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography (DSE)
Number of subjects: 20
Study 15592928 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-[11C]CGP12388 PET
Number of subjects: 6
Study 15592928 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 6
Study 11880018 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP 14/8 cm H(2)O with RR at 10 breaths/min
Number of subjects: 213
Study 11880018 — intervention group
Group type: COMPARATOR
Intervention: CPAP 8 cm H(2)O
Number of subjects: 213
Study 11880018 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP 14/8 cm H(2)O
Number of subjects: 213
Study 11880018 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid induction with 2.0 mg/kg propofol followed by P5
Number of subjects: 213
Study 9795848 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification and implantation of a silicone IOL with posterior continuous curvilinear capsulorhexis (PCCC)
Number of subjects: 50
Study 9795848 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification and implantation of a silicone IOL without PCCC (control group)
Number of subjects: 50
Study 9795848 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PCCC)
Number of subjects: 50
Study 9795848 — intervention group
Group type: EXPERIMENTAL
Intervention: PCCC group
Number of subjects: 50
Study 7652118 — intervention group
Group type: EXPERIMENTAL
Intervention: New method of estimating baroreflex control from spontaneous changes in systolic pressure and pulse interval
Number of subjects: 0
Study 7652118 — intervention group
Group type: COMPARATOR
Intervention: Conventional method of assessing baroreflex control through pharmacological manipulations of blood pressure
Number of subjects: 0
Study 2509250 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (LA) depot treatment, 3.75 mg IM every 4 weeks for 12 weeks (group A)
Number of subjects: 18
Study 2509250 — intervention group
Group type: COMPARATOR
Intervention: Placebo IM injection every 4 weeks for 12 weeks (group B)
Number of subjects: 18
Study 2509250 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (LA) depot treatment, 3.75 mg IM every 4 weeks for 12 weeks (group A) in patients with large uteri
Number of subjects: 18
Study 2509250 — intervention group
Group type: COMPARATOR
Intervention: Placebo IM injection every 4 weeks for 12 weeks (group B) in patients with large uteri
Number of subjects: 18
Study 326403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ftorafur combined with mitomycin C
Number of subjects: 25
Study 326403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ftorafur combined with methyl-CCNU
Number of subjects: 25
Study 31617096 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure carbon dioxide pneumoperitoneum (8 mm Hg)
Number of subjects: 101
Study 31617096 — intervention group
Group type: COMPARATOR
Intervention: High-pressure carbon dioxide pneumoperitoneum (14 mm Hg)
Number of subjects: 101
Study 31883249 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissurit FX sealant
Number of subjects: 55
Study 31883249 — intervention group
Group type: COMPARATOR
Intervention: Grandioseal nanofilled fissure sealant
Number of subjects: 55
Study 28720281 — intervention group
Group type: EXPERIMENTAL
Intervention: H9N2 vaccine with AS03 adjuvant (1.9µgHA+AS03A, 1.9µgHA+AS03B, 3.75µgHA+AS03A, 3.75µgHA+AS03B)
Number of subjects: 420
Study 28720281 — intervention group
Group type: EXPERIMENTAL
Intervention: H9N2 vaccine without adjuvant (15µg HA)
Number of subjects: 420
Study 28720281 — intervention group
Group type: EXPERIMENTAL
Intervention: H9N2 vaccine (any formulation) administered a third dose on day 182
Number of subjects: 420
Study 28720281 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 420
Study 25673443 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii Hook F (TwHF) 20 mg, 3 times a day for 8 weeks
Number of subjects: 115
Study 25673443 — intervention group
Group type: COMPARATOR
Intervention: Acitretin 30 mg, once a day for 8 weeks
Number of subjects: 115
Study 25673443 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii Hook F (TwHF)
Number of subjects: 115
Study 25673443 — intervention group
Group type: COMPARATOR
Intervention: Acitretin
Number of subjects: 115
Study 24968737 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IU) every 14 days for 4 months
Number of subjects: 53
Study 21849541 — intervention group
Group type: EXPERIMENTAL
Intervention: One week of training on complex visuomotor rotation
Number of subjects: 0
Study 19501984 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase (F)
Number of subjects: 138
Study 19501984 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase (L)
Number of subjects: 138
Study 17714105 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 15
Study 17714105 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 15
Study 15171574 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid above-knee plaster dressing applied at operation (n = 78)
Number of subjects: 154
Study 15171574 — intervention group
Group type: COMPARATOR
Intervention: Non-rigid dressing regime (control group, n = 76)
Number of subjects: 154
Study 15171574 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid dressing
Number of subjects: 154
Study 15171574 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-trial questionnaire responses
Number of subjects: 154
Study 11570650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 45
Study 11570650 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 45
Study 11570650 — intervention group
Group type: COMPARATOR
Intervention: Control (doing nothing)
Number of subjects: 45
Study 11570650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking and Chewing gum
Number of subjects: 45
Study 9135191 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 97
Study 9135191 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 97
Study 9135191 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 97
Study 7911132 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam+exposure (AE)
Number of subjects: 144
Study 7911132 — intervention group
Group type: COMPARATOR
Intervention: placebo+exposure (PE)
Number of subjects: 144
Study 7911132 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam+relaxation (AR)
Number of subjects: 144
Study 7911132 — intervention group
Group type: COMPARATOR
Intervention: placebo+relaxation (PR)
Number of subjects: 144
Study 3318436 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone (1,000 mg taken at bedtime)
Number of subjects: 489
Study 3318436 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (250 mg twice daily)
Number of subjects: 489
Study 3318436 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 489
Study 3318436 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 489
Study 31900091 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic exercises and relaxing techniques, performed twice a week for one month.
Number of subjects: 19
Study 31900091 — intervention group
Group type: COMPARATOR
Intervention: Self-care guidelines (Control group).
Number of subjects: 19
Study 30550400 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected motivational music
Number of subjects: 17
Study 30550400 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 17
Study 28974425 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent heat device (n=25)
Number of subjects: 81
Study 28974425 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal spray (n=28)
Number of subjects: 81
Study 28974425 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated warm compress (n=28)
Number of subjects: 81
Study 28974425 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MG dropout)
Number of subjects: 81
Study 26970217 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐delivered sleep‐promoting interventions augmented by sleep hygiene education and environmental control to minimize sleep disruption
Number of subjects: 112
Study 26970217 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐delivered sleep‐promoting interventions
Number of subjects: 112
Study 24736285 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 185
Study 24736285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 21242856 — intervention group
Group type: EXPERIMENTAL
Intervention: Head elevation increased or decreased between 0 and 40 degrees from baseline level (30 degrees) in increments or decrements of 10 degrees
Number of subjects: 10
Study 20951301 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adjusting file (SAF) system with continuous irrigation
Number of subjects: 40
Study 20951301 — intervention group
Group type: COMPARATOR
Intervention: Rotary nickel-titanium (NiTi) instrumentation with syringe/needle irrigation
Number of subjects: 40
Study 20951301 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified sampling technique (S2b)
Number of subjects: 40
Study 17394002 — intervention group
Group type: EXPERIMENTAL
Intervention: Household common salt solution (10 g NaCl in 1 l tap water)
Number of subjects: 126
Study 17394002 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol with electrolytes (PEG)
Number of subjects: 126
Study 17394002 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer lactate
Number of subjects: 126
Study 15856433 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 18
Study 11952881 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Insulin Injection (MI) therapy for 9 weeks
Number of subjects: 20
Study 11952881 — intervention group
Group type: COMPARATOR
Intervention: Bedtime Insulin (BTI)
Number of subjects: 20
Study 8557215 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 fibres in the periphery of muscle fascicles
Number of subjects: 19
Study 8557215 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related changes in muscle fibre diameter
Number of subjects: 19
Study 2694492 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensilon (edrophonium) administered at 2 hours
Number of subjects: 8
Study 2694492 — intervention group
Group type: COMPARATOR
Intervention: Philippine cobra antivenom (20, 50 or 100 ml) administered by constant intravenous infusion over 30 min
Number of subjects: 8
Study 412611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphur dioxide
Number of subjects: 272
Study 412611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate
Number of subjects: 272
Study 412611 — intervention group
Group type: EXPERIMENTAL
Intervention: Tartrazine
Number of subjects: 272
Study 412611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (prior inhalation)
Number of subjects: 272
Study 412611 — intervention group
Group type: COMPARATOR
Intervention: Control (no reaction)
Number of subjects: 272
Study 31236690 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD group (n = 331)
Number of subjects: 1804
Study 31236690 — intervention group
Group type: COMPARATOR
Intervention: no-ICD group (n = 1473)
Number of subjects: 1804
Study 31961936 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent enteral feedings 5 times daily at 4-hour intervals
Number of subjects: 50
Study 31961936 — intervention group
Group type: COMPARATOR
Intervention: Intermittent enteral feedings 10 times daily at 2-hour intervals
Number of subjects: 50
Study 28602319 — intervention group
Group type: EXPERIMENTAL
Intervention: OMS302 (Omidria [phenylephrine and ketorolac injection 1.0%/0.3%])
Number of subjects: 223
Study 28602319 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (balanced salt solution)
Number of subjects: 223
Study 28602319 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac
Number of subjects: 223
Study 28602319 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 223
Study 27382753 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block (SGB) with ropivacaine
Number of subjects: 80
Study 27382753 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 80
Study 23375310 — intervention group
Group type: EXPERIMENTAL
Intervention: Active humidification (AH) using a heated humidifier (HH group, n = 17)
Number of subjects: 34
Study 23375310 — intervention group
Group type: COMPARATOR
Intervention: Passive humidification (PH) using a heat-and-moisture exchanger (HME group, n = 17)
Number of subjects: 34
Study 21909493 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling (FMS)
Number of subjects: 37
Study 21909493 — intervention group
Group type: COMPARATOR
Intervention: Conventional scaling and root planing (cSRP)
Number of subjects: 37
Study 21909493 — intervention group
Group type: COMPARATOR
Intervention: Control group (cSRP)
Number of subjects: 37
Study 19828955 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mesalazine (4 g) + topical mesalazine enema (1 g)
Number of subjects: 0
Study 19828955 — intervention group
Group type: COMPARATOR
Intervention: Oral mesalazine (4 g) alone
Number of subjects: 0
Study 19828955 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine enema
Number of subjects: 0
Study 17006600 — intervention group
Group type: EXPERIMENTAL
Intervention: L-methionine (active treatment)
Number of subjects: 253
Study 17006600 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 253
Study 15609843 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cervical traction and electrotherapy/exercise
Number of subjects: 30
Study 15609843 — intervention group
Group type: COMPARATOR
Intervention: Electrotherapy/exercise (control)
Number of subjects: 30
Study 11726725 — intervention group
Group type: EXPERIMENTAL
Intervention: apoE4 phenotype
Number of subjects: 36
Study 11726725 — intervention group
Group type: COMPARATOR
Intervention: apoE 3/3 phenotype
Number of subjects: 36
Study 10052279 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term pulmonary rehabilitation (group I)
Number of subjects: 45
Study 10052279 — intervention group
Group type: COMPARATOR
Intervention: No pulmonary rehabilitation (group II)
Number of subjects: 45
Study 8294085 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha treatment
Number of subjects: 100
Study 8294085 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 100
Study 8294085 — intervention group
Group type: COMPARATOR
Intervention: Branched-DNA assay
Number of subjects: 100
Study 2557304 — intervention group
Group type: EXPERIMENTAL
Intervention: V‐CAP plus TRT
Number of subjects: 126
Study 2557304 — intervention group
Group type: COMPARATOR
Intervention: CAP plus TRT
Number of subjects: 126
Study 2557304 — intervention group
Group type: COMPARATOR
Intervention: TRT (Thoracic Radiation Therapy)
Number of subjects: 126
Study 2557304 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 126
Study 2557304 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure patterns
Number of subjects: 126
Study 2557304 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic variables
Number of subjects: 126
Study 4310020 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin sulphomethate sodium B.P. (Colomycin)
Number of subjects: 0
Study 4310020 — intervention group
Group type: EXPERIMENTAL
Intervention: Pento‐N sulphomethylpolymyxin B sodium (Thiosporin)
Number of subjects: 0
Study 4310020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin B.P. (Penbritin)
Number of subjects: 0
Study 4310020 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study 29294858 — intervention group
Group type: EXPERIMENTAL
Intervention: TakeCARE video in a monitored computer lab
Number of subjects: 557
Study 29294858 — intervention group
Group type: EXPERIMENTAL
Intervention: TakeCARE video at their own convenience after receiving an email link
Number of subjects: 557
Study 29294858 — intervention group
Group type: COMPARATOR
Intervention: Control video about study skills
Number of subjects: 557
Study 31781699 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded implants with provisional resin fixed partial denture
Number of subjects: 26
Study 31781699 — intervention group
Group type: COMPARATOR
Intervention: Conventionally loaded implants according to the one-stage unloaded protocol
Number of subjects: 26
Study 31781699 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (immediately loaded and conventionally loaded)
Number of subjects: 26
Study 28993007 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 273
Study 25966791 — intervention group
Group type: EXPERIMENTAL
Intervention: Balugrastim 30 mg
Number of subjects: 98
Study 25966791 — intervention group
Group type: EXPERIMENTAL
Intervention: Balugrastim 40 mg
Number of subjects: 98
Study 25966791 — intervention group
Group type: EXPERIMENTAL
Intervention: Balugrastim 50 mg
Number of subjects: 98
Study 25966791 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 98
Study 23496322 — intervention group
Group type: EXPERIMENTAL
Intervention: tTF‐NGR
Number of subjects: 0
Study 23496322 — intervention group
Group type: EXPERIMENTAL
Intervention: TMS(PEG)12 tTF‐NGR
Number of subjects: 0
Study 23496322 — intervention group
Group type: EXPERIMENTAL
Intervention: PEGylation of tTF‐NGR
Number of subjects: 0
Study 20932159 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic oligopeptide-coated bone mineral with collagen membrane
Number of subjects: 42
Study 20932159 — intervention group
Group type: COMPARATOR
Intervention: Bone graft without peptide with collagen membrane
Number of subjects: 42
Study 19386307 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic argon plasma coagulation (APC)
Number of subjects: 600
Study 19386307 — intervention group
Group type: COMPARATOR
Intervention: Control group (no APC)
Number of subjects: 600
Study 17011447 — intervention group
Group type: EXPERIMENTAL
Intervention: Log-pEBV DNA
Number of subjects: 57
Study 17011447 — intervention group
Group type: EXPERIMENTAL
Intervention: sq-T(vol)
Number of subjects: 57
Study 17011447 — intervention group
Group type: EXPERIMENTAL
Intervention: sq-N(vol)
Number of subjects: 57
Study 17011447 — intervention group
Group type: EXPERIMENTAL
Intervention: T(suv)
Number of subjects: 57
Study 17011447 — intervention group
Group type: EXPERIMENTAL
Intervention: N(suv)
Number of subjects: 57
Study 15333415 — intervention group
Group type: EXPERIMENTAL
Intervention: etoricoxib 120 mg
Number of subjects: 225
Study 15333415 — intervention group
Group type: EXPERIMENTAL
Intervention: oxycodone/acetaminophen 10/650 mg
Number of subjects: 225
Study 15333415 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 225
Study 11117368 — intervention group
Group type: EXPERIMENTAL
Intervention: RS‐127445 (500 mg)
Number of subjects: 6
Study 11117368 — intervention group
Group type: COMPARATOR
Intervention: 5-HT (0.5 ng/kg/min)
Number of subjects: 6
Study 9122731 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon alpha (rIFN‐alpha) as a single agent
Number of subjects: 0
Study 9122731 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rIFN‐alpha with recombinant interleukin‐2 (rIL‐2)
Number of subjects: 0
Study 9122731 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rIFN‐alpha with combination chemotherapy regimens
Number of subjects: 0
Study 9122731 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy using dual biologic agents
Number of subjects: 0
Study 7849443 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoadsorption (IMA)
Number of subjects: 8
Study 7849443 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran sulfate cellulose adsorption (DSA)
Number of subjects: 8
Study 3060872 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 117
Study 3060872 — intervention group
Group type: COMPARATOR
Intervention: Tiabendazole plus Flubendazole
Number of subjects: 117
Study 30323328 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis) for 6 months
Number of subjects: 290
Study 30323328 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 290
Study 28498191 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother Support Groups (MSGs) established in 14 clinics, meeting every 2 weeks, coordinated by volunteer HIV-positive mothers.
Number of subjects: 348
Study 28498191 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no MSGs).
Number of subjects: 348